FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2902609064> ?p ?o ?g. }

• W2902609064 endingPage "93" @default.
• W2902609064 startingPage "82" @default.
• W2902609064 abstract "Purpose To investigate clinical and biological factors influencing recurrences of severe toxoplasmic retinochoroiditis (TRC) confirmed by aqueous humor analysis. Design Retrospective case series. Methods Retrospective analysis of 87 subjects with severe TRC, proven by positive Goldmann-Witmer coefficient (GWC), Toxoplasma gondii (T. gondii) immunoblot, or T. gondii–specific polymerase chain reaction (PCR) in aqueous humor. Cases with immunosuppression or retinal scars without previous recorded episode were excluded. Time-dependent, clinical, treatment-related, and biological factors were explored by univariate and multivariate shared frailty survival analyses. Results Among 44 included subjects (age, 40.4 ± 17.6 years; follow-up, 8.3 ± 2.7 years), 22 presented recurrences. There was 0.11 recurrence/patient/year and mean disease-free interval was 5.0 ± 2.9 years. The risk of recurrence was higher immediately after an episode (P < .0001). Among recurrent cases, the risk of multiple recurrences was higher when the first recurrence occurred after longer disease-free intervals (P = .046). In univariate analysis, the recurrence risk declined with higher number of intense bands on aqueous T. gondii immunoblot (P = .006), and increased when venous vasculitis was present initially (P = .019). Multivariate analysis confirmed that eyes with more intense bands on immunoblot had fewer recurrences (P = .041). There was a near-significant risk elevation after pyrimethamine/azithromycin treatment (P = .078 and P = .054, univariate and multivariate). Intravenous corticosteroid administration, oral corticosteroid administration, aqueous GWC, and T. gondii PCR did not influence recurrences (P = .12, P = .10, P = .39, and P = .96, respectively). Conclusions Recurrences of severe TRC are not random and may be influenced by clinical and biological factors possibly related to blood-retinal barrier alterations. These results may contribute to identifying biomarkers for TRC reactivation. To investigate clinical and biological factors influencing recurrences of severe toxoplasmic retinochoroiditis (TRC) confirmed by aqueous humor analysis. Retrospective case series. Retrospective analysis of 87 subjects with severe TRC, proven by positive Goldmann-Witmer coefficient (GWC), Toxoplasma gondii (T. gondii) immunoblot, or T. gondii–specific polymerase chain reaction (PCR) in aqueous humor. Cases with immunosuppression or retinal scars without previous recorded episode were excluded. Time-dependent, clinical, treatment-related, and biological factors were explored by univariate and multivariate shared frailty survival analyses. Among 44 included subjects (age, 40.4 ± 17.6 years; follow-up, 8.3 ± 2.7 years), 22 presented recurrences. There was 0.11 recurrence/patient/year and mean disease-free interval was 5.0 ± 2.9 years. The risk of recurrence was higher immediately after an episode (P < .0001). Among recurrent cases, the risk of multiple recurrences was higher when the first recurrence occurred after longer disease-free intervals (P = .046). In univariate analysis, the recurrence risk declined with higher number of intense bands on aqueous T. gondii immunoblot (P = .006), and increased when venous vasculitis was present initially (P = .019). Multivariate analysis confirmed that eyes with more intense bands on immunoblot had fewer recurrences (P = .041). There was a near-significant risk elevation after pyrimethamine/azithromycin treatment (P = .078 and P = .054, univariate and multivariate). Intravenous corticosteroid administration, oral corticosteroid administration, aqueous GWC, and T. gondii PCR did not influence recurrences (P = .12, P = .10, P = .39, and P = .96, respectively). Recurrences of severe TRC are not random and may be influenced by clinical and biological factors possibly related to blood-retinal barrier alterations. These results may contribute to identifying biomarkers for TRC reactivation." @default.
• W2902609064 created "2018-12-11" @default.
• W2902609064 creator A5012409046 @default.
• W2902609064 creator A5024226918 @default.
• W2902609064 creator A5025916991 @default.
• W2902609064 creator A5044926681 @default.
• W2902609064 creator A5067382683 @default.
• W2902609064 creator A5072243132 @default.
• W2902609064 creator A5075584830 @default.
• W2902609064 creator A5080511702 @default.
• W2902609064 creator A5086216178 @default.
• W2902609064 creator A5086590031 @default.
• W2902609064 date "2019-03-01" @default.
• W2902609064 modified "2023-10-11" @default.
• W2902609064 title "Clinical and Biological Factors Associated With Recurrences of Severe Toxoplasmic Retinochoroiditis Confirmed by Aqueous Humor Analysis" @default.
• W2902609064 cites W1572515873 @default.
• W2902609064 cites W1889288769 @default.
• W2902609064 cites W190025028 @default.
• W2902609064 cites W1968593778 @default.
• W2902609064 cites W1976363419 @default.
• W2902609064 cites W1976689464 @default.
• W2902609064 cites W1984706770 @default.
• W2902609064 cites W2016341989 @default.
• W2902609064 cites W2022426547 @default.
• W2902609064 cites W2023922080 @default.
• W2902609064 cites W2024385097 @default.
• W2902609064 cites W2028572954 @default.
• W2902609064 cites W2031029755 @default.
• W2902609064 cites W2031490445 @default.
• W2902609064 cites W2033103553 @default.
• W2902609064 cites W2042765236 @default.
• W2902609064 cites W2065038571 @default.
• W2902609064 cites W2072250538 @default.
• W2902609064 cites W2073645035 @default.
• W2902609064 cites W2076807882 @default.
• W2902609064 cites W2081724399 @default.
• W2902609064 cites W2082879528 @default.
• W2902609064 cites W2092692836 @default.
• W2902609064 cites W2099428729 @default.
• W2902609064 cites W2108919154 @default.
• W2902609064 cites W2111257740 @default.
• W2902609064 cites W2116826131 @default.
• W2902609064 cites W2131421899 @default.
• W2902609064 cites W2138886104 @default.
• W2902609064 cites W2139499737 @default.
• W2902609064 cites W2142713800 @default.
• W2902609064 cites W2162986598 @default.
• W2902609064 cites W2166183552 @default.
• W2902609064 cites W2312240637 @default.
• W2902609064 cites W2315854316 @default.
• W2902609064 cites W2321390659 @default.
• W2902609064 cites W2322015722 @default.
• W2902609064 cites W2323096252 @default.
• W2902609064 cites W2417062091 @default.
• W2902609064 cites W2476427637 @default.
• W2902609064 cites W2620999239 @default.
• W2902609064 cites W4234832863 @default.
• W2902609064 doi "https://doi.org/10.1016/j.ajo.2018.11.013" @default.
• W2902609064 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30502335" @default.
• W2902609064 hasPublicationYear "2019" @default.
• W2902609064 type Work @default.
• W2902609064 sameAs 2902609064 @default.
• W2902609064 citedByCount "10" @default.
• W2902609064 countsByYear W29026090642020 @default.
• W2902609064 countsByYear W29026090642021 @default.
• W2902609064 countsByYear W29026090642022 @default.
• W2902609064 crossrefType "journal-article" @default.
• W2902609064 hasAuthorship W2902609064A5012409046 @default.
• W2902609064 hasAuthorship W2902609064A5024226918 @default.
• W2902609064 hasAuthorship W2902609064A5025916991 @default.
• W2902609064 hasAuthorship W2902609064A5044926681 @default.
• W2902609064 hasAuthorship W2902609064A5067382683 @default.
• W2902609064 hasAuthorship W2902609064A5072243132 @default.
• W2902609064 hasAuthorship W2902609064A5075584830 @default.
• W2902609064 hasAuthorship W2902609064A5080511702 @default.
• W2902609064 hasAuthorship W2902609064A5086216178 @default.
• W2902609064 hasAuthorship W2902609064A5086590031 @default.
• W2902609064 hasConcept C126322002 @default.
• W2902609064 hasConcept C141071460 @default.
• W2902609064 hasConcept C142724271 @default.
• W2902609064 hasConcept C144301174 @default.
• W2902609064 hasConcept C159654299 @default.
• W2902609064 hasConcept C167135981 @default.
• W2902609064 hasConcept C203014093 @default.
• W2902609064 hasConcept C2778062946 @default.
• W2902609064 hasConcept C2778128430 @default.
• W2902609064 hasConcept C2780252810 @default.
• W2902609064 hasConcept C38180746 @default.
• W2902609064 hasConcept C71924100 @default.
• W2902609064 hasConcept C90924648 @default.
• W2902609064 hasConceptScore W2902609064C126322002 @default.
• W2902609064 hasConceptScore W2902609064C141071460 @default.
• W2902609064 hasConceptScore W2902609064C142724271 @default.
• W2902609064 hasConceptScore W2902609064C144301174 @default.
• W2902609064 hasConceptScore W2902609064C159654299 @default.
• W2902609064 hasConceptScore W2902609064C167135981 @default.
• W2902609064 hasConceptScore W2902609064C203014093 @default.
• W2902609064 hasConceptScore W2902609064C2778062946 @default.

• next